Inndura Therapeutics (Uk) Limited
14240690
Healthy
No risk factors detected.
Details
Compliance
Last accounts
31/12/2025
total exemption full
Next accounts due
30/09/2027
Confirmation statement
Last: 17/07/2026
Due 31/07/2027
Industry
Officers
Persons with Significant Control
Kin Fei Adrian Chan
Singaporean · Hong Kong
Notified 30/08/2024
Former PSCs
John Beadle
Ceased 30/08/2024
CompanyRankvs 2241+ SIC 72110 peers40
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2025
Net Worth
£27k
Balance sheet strength
Cash
£805
Cash in the bank
Net Current Assets
—
Working capital
Current Assets
—
Current Liabilities
£4k
Debtors
£30k
Tax at Year End(2024)
EstimatesDerived
| Year | Current Ratio |
|---|---|
| 2024 | 5.82 |
Derived from filed accounts. Not audited figures.